Latest Initial Public Offering (IPO) News

The National Council on Disability Urges Expeditious Senate Approval of the Convention on the Rights of Persons with DisabilitiesSeven Senators pledge their support for U.S. ratification of the CRPD WASHINGTON, May 26, 2012 /PRNewswire-USNewswire/ -- Today, seven United States Senators issued a statement of bipartisan support for United States ratification of the Convention on the Rights of Persons with Disabilities. (Logo: http://photos.prnewswire.com/prnh/20110601/DC11812LOGO) "The Convention was undertake...

Bel Marra Health Supports a Recent Study Out of UCLA that Shows a Link Between Sugar and Brain HealthBel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows there is a tie between sugar and brain health. Toronto, ON (PRWEB) May 26, 2012 Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows there is a tie be...

Apollo Group's White Dental Clinic offers high end clinical─cosmetic procedures to save natural teethWhite Dental Clinic, an Apollo Group initiative, is offering Micro Dentistry and Snap─on─Smile which would prove to be economical in the long run for patients.

Joy Keys Chats with the Faces of Stroke AmbassadorsPhiladelphia, PA, May 26, 2012 --(PR.com)-- Faces of Stroke Ambassadors Date: May 26th, 2012 Time: 11:00 a.m. – 11:30 a.m. ET Call In Number: 646-929-0368. Url: http://www.blogtalkradio.com/joykeys/2012/05/26/joy-keys-chats-with-the-faces-of-stroke-ambassadors Lenice Hogan: Hogan is a survivor of not one stroke, but three, all at young ages. She survived hemorrhagic strokes at the ages...

Great Wall Chinese Medicine Has a Big Event on DiabetesScottsdale, AZ, May 26, 2012 --(PR.com)-- The China Academy of Chinese Medical Sciences (CACMS) is the largest and most prestigious TCM research organization in China. CACMS coordinates joint efforts with the World Health organization. CACMS and Great Wall Chinese Medicine have joined together to establish a partnership to serve the community through an ongoing seminar series focusing on how both...

Luddite Greens repeatedly and viscerally anti-science - Take the Flour Back is the latest incarnationAdam Rutherford in the comments at Comment is free does a better job than Sunny Hundal, so let's accept Sense About Science's Tweeted suggestion and promote him to top billing:Dear Sunny,Some interesting points, and a considered pov, as usual. A couple of things worth noting. I'm interested in the longview of opposition to biotechnology that is based on recombinant DNA. Since its discovery/inventi...

Doctors opposed to NHS reforms set up a new political partyA group of doctors and public health experts, disillusioned by the government’s changes to the NHS, are setting up a new political party because they don’t think that any of the existing parties...

BIO Applauds EPA’s Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel StandardThe Biotechnology Industry Organization (BIO) today expressed support for the Environmental Protection Agency’s denial of a January 2012 petition by petroleum industry representatives to retroactively waive the 2011 cellulosic biofuel Renewable Volume Obligation under the Renewable Fuel Standard (RFS). Brent Erickson, executive vice president of BIO’s...

California tobacco tax measure risks going up in smokeSAN FRANCISCO (Reuters) - Health-conscious Californians may mostly oppose smoking for its costs to public health and the economy but an aggressive tobacco industry campaign and general anti-tax sentiment may block a measure to raise taxes on smokers....

Delcath raises $20 millionDrug delivery company Delcath Systems Inc. (NASDAQ:DCTH) raised $20 million through the sale of 13.3 million units at $1.50 per unit in a follow-on underwritten by Cowen; Wedbush; and Roth. Each unit comprises a share and a three-year warrant to purc...

Harry F. Kuhn II is recognized by Continental Who's Who as a Pinnacle Professional in the field of clinical social workSOUTH PLAINFIELD, N.J., May 25, 2012 /PRNewswire/ -- Continental Who's Who -- Harry F. Kuhn III, the 802nd clinical social worker to be licensed by the State of New Jersey in its inaugural licensure year of 1991, a currently practicing State certified bilingual school social worker since 1973, and an American Board-certified diplomate in clinical social work, is recognized by Continental Who's Who...

Human medicines European Public Assessment Report (EPAR): Renagel, sevelamer, Revision: 19, Authorised

Human medicines European Public Assessment Report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 6, Authorised

Human medicines European Public Assessment Report (EPAR): Liprolog, insulin lispro, Revision: 14, Authorised

Veterinary medicine European Public Assessment Report (EPAR): Convenia, Cefovecin, Revision: 6, Authorised

VA Continues Long-Term Study on Gulf War Era VeteransFor the third time since the 1990-1991 Gulf War, Department of Veterans Affairs (VA) researchers will contact Gulf War-era Veterans as a part of a long-term study of their health. “Our message to our Gulf War Veterans is clear: We are not forgetting you, we are listening to you, and we are acting,” said Secretary of Veterans Affairs Eric K. Sh...

Innovative public-private collaboration to tackle antibiotic researchAstraZeneca and GlaxoSmithKline has welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic r...

FDA’s public hearing on biosimilars draft guidancesOn 11 May 2012, FDA held a public hearing to gain input on their draft guidances relating to the development of biosimilar products and it seems that the guidances were generally well accepted.

European Medicines Agency Confirms Positive Benefit-Risk Balance of MabtheraBatches produced at the Vacaville manufacturing site do not pose risk to public health Following a quality review of the genetically engineered monoclonal antibody MabThera, the European Medicines Agency’s Committee for Medicinal Products...

Despite challenges, U.S. GHI moves toward integrated approach to global public healthIn this Lancet opinion piece, Jennifer Kates, vice president and director of global health and HIV policy for the Kaiser Family Foundation, and Josh Michaud, principal policy analyst at the Foundation, examine the U.S. Global Health Initiative (GHI),...

Capitol Hill briefing addresses research agenda to end AIDS epidemicIn a guest blog post on the Center for Global Health Policy's "Science Speaks," Chris Collins, vice president and director of public policy at amfAR: The Foundation for AIDS Research, and Mitchell Warren, executive director of AVAC: Global Advocacy f...

UPDATE 3-Germany's Evonik to brave jittery IPO marketFRANKFURT, May 25 (Reuters) - German chemicals firm Evonik is pressing ahead with plans to list in Frankfurt, unfazed by the euro zone debt crisis and the debacle over Facebook's market debut, in what could be Europe's largest initial public offerin...

Rwanda Takes Major Step to Stem Child Diarrheal DeathsRwanda today accelerated its fight against rotavirus, the primary cause of deadly diarrhea in young children, when it became the fourth African country to introduce new rotavirus vaccines only recently made available to developing countries. Rotavirus is the primary cause of diarrhea in children. In Rwanda, diarrhea accounts for approximately 23% of child...

Malvern Releases New White Paper Offering Expert Guidance for Rheological Measurement of Yield StressA new white paper from Malvern Instruments is aimed at helping product developers and formulators get to grips with the measurement of yield stress. A performance-defining parameter in products from...

News and press releases: European Medicines Agency confirms positive benefit-risk balance of MabTheraFollowing a quality review of the genetically engineered monoclonal antibody MabThera, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the batches of the active substance of MabThera, rituxim...

0 1 2 3 4 ›»

buy Initial Public Offering (IPO) market research data and corporate reports now Advertisement